Targeting Wnt signaling in myeloma in vivo; Differential effects on tumor burden and myeloma bone disease

Registros relacionados

• Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.
  por: Edwards, C, et al.
  Publicado em: (2008)
• EphB4 Expression in Osteoblasts is Regulated by Myeloma Cells and the Wnt Signaling Pathway.
  por: Bates, A, et al.
  Publicado em: (2008)
• Wnt signaling: bone's defense against myeloma.
  por: Edwards, C
  Publicado em: (2008)
• Decreased bone marrow-derived adiponectin contributes to myeloma pathogenesis in vivo
  por: Fowler, J, et al.
  Publicado em: (2010)
• Lithium inhibits the development of myeloma bone disease in vivo.
  por: Edwards, C, et al.
  Publicado em: (2006)